We are live on
!
Find out more
1832 Asset Management Portfolio holdings
AUM
$109B
1-Year Est. Return
35.56%
This Fund
S&P 500
This Quarter
Est. Return
-6.71%
1 Year Est. Return
+35.56%
3 Year Est. Return
+103.97%
5 Year Est. Return
+158.4%
10 Year Est. Return
+629.65%
AUM
$23.9B
AUM Growth
-$5.57B
(-19%)
Cap. Flow
-$3.33B
Cap. Flow
% of AUM
-13.93%
Top 10 Holdings %
Top 10 Hldgs %
23.69%
Holding
758
New
84
Increased
178
Reduced
242
Closed
129
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Becton Dickinson
BDX
|
+$269M |
| 2 |
AET
Aetna Inc
AET
|
+$214M |
| 3 |
Automatic Data Processing
ADP
|
+$178M |
| 4 |
CVS Health
CVS
|
+$149M |
| 5 |
Visa
V
|
+$100M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$304M |
| 2 |
Union Pacific
UNP
|
+$198M |
| 3 |
Apple
AAPL
|
+$186M |
| 4 |
Vanguard Health Care ETF
VHT
|
+$160M |
| 5 |
Vanguard Consumer Discretionary ETF
VCR
|
+$158M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 24.41% |
| 2 | Healthcare | 13.16% |
| 3 | Communication Services | 10.95% |
| 4 | Industrials | 10.1% |
| 5 | Consumer Discretionary | 10.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Novartis
NVS
$302B
| $51.8M | 0.22% |
627,506
+81,049
| +15% | +$7.21M |
|
102
Celestica
CLS
$37.8B
| $51.7M | 0.22% |
4,015,230
-1,887,200
| -32% | -$23.3M |
|
103
Tesla
TSLA
$1.18T
| $51.1M | 0.21% |
3,171,750
+1,163,550
| +58% | +$19.8M |
|
104
Estee Lauder
EL
$30.4B
| $50.9M | 0.21% |
629,420
+96,530
| +18% | +$8.09M |
|
105
Bath & Body Works
BBWI
$3.97B
| $50.6M | 0.21% |
691,673
+687,005
| +14,717% | +$47.5M |
|
106
Biogen
BIIB
$30.9B
| $50.5M | 0.21% |
172,340
-34,449
| -17% | -$11.4M |
|
107
Cognizant
CTSH
$25.2B
| $48.6M | 0.2% |
+774,150
| New | +$48.6M |
|
108
Thermo Fisher Scientific
TMO
$214B
| $48.5M | 0.2% |
395,810
-26,145
| -6% | -$3.41M |
|
109
Ecolab
ECL
$79.8B
| $47M | 0.2% |
427,665
-2,725
| -0.6% | -$305K |
|
110
Amphenol
APH
$185B
| $47M | 0.2% |
3,674,800
+618,572
| +20% | +$8.31M |
|
111
Goldman Sachs
GS
$289B
| $47M | 0.2% |
269,300
+269,000
| +89,667% | +$52.7M |
|
112
Lazard
LAZ
$3.96B
| $46.1M | 0.19% |
1,071,870
+137,307
| +15% | +$7.07M |
|
113
Trane Technologies
TT
$98.8B
| $45.6M | 0.19% |
904,098
-296,907
| -25% | -$17.7M |
|
114
Paycom
PAYC
$7.88B
| $45.3M | 0.19% |
1,295,900
+3,900
| +0.3% | +$142K |
|
|
WBA
115
DELISTED
Walgreens Boots Alliance
WBA
| $44.7M | 0.19% |
536,083
+490,966
| +1,088% | +$44.4M |
|
116
Allegion
ALLE
$13.5B
| $44.2M | 0.18% |
764,280
-66,580
| -8% | -$4.06M |
|
|
TWX
117
DELISTED
Time Warner Inc
TWX
| $43.9M | 0.18% |
635,810
+593,977
| +1,420% | +$46.7M |
|
118
General Dynamics
GD
$103B
| $43.3M | 0.18% |
312,751
+26,460
| +9% | +$3.83M |
|
119
TJX Companies
TJX
$179B
| $42.8M | 0.18% |
+1,195,400
| New | +$41.9M |
|
120
NetEase
NTES
$83B
| $42.1M | 0.18% |
1,747,500
+358,500
| +26% | +$9.24M |
|
121
Pfizer
PFE
$143B
| $41.5M | 0.17% |
1,406,945
-934,010
| -40% | -$29.9M |
|
|
GG
122
DELISTED
Goldcorp Inc
GG
| $41.4M | 0.17% |
3,304,537
-1,733,133
| -34% | -$24.2M |
|
123
Teva Pharmaceuticals
TEVA
$40.4B
| $41M | 0.17% |
723,219
+5,040
| +0.7% | +$327K |
|
|
FRC
124
DELISTED
First Republic Bank
FRC
| $40M | 0.17% |
634,780
+272,080
| +75% | +$17M |
|
125
Starbucks
SBUX
$119B
| $39.4M | 0.16% |
691,015
-460,025
| -40% | -$25.8M |
|
Similar funds
1832 Asset Management's Q3 2015 Portfolio in Review
As of Q3 2015, 1832 Asset Management held 758 positions worth $23.9B, down 19% from $29.5B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
1832 Asset Management withdrew a net $3.33B in Q3 2015, closing 129 positions and reducing 242 holdings. Its most notable exit was Vanguard Health Care ETF, an estimated $160M position sold in full.
By sector, the portfolio is most concentrated in Financials at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Communication Services.
Against the trend, 1832 Asset Management opened a new position in Incyte worth $93.8M.
- 1832 Asset Management's largest Q3 2015 buy was Incyte: 864,800 shares worth $93.8M.
- 1832 Asset Management added most to Becton Dickinson in Q3 2015, an estimated $269M increase.
- 1832 Asset Management's biggest Q3 2015 reduction was Walt Disney, cutting an estimated $304M.
- 1832 Asset Management fully exited Vanguard Health Care ETF in Q3 2015, selling an estimated $160M.
- 1832 Asset Management's ten largest holdings make up 24% of its $23.9B portfolio in Q3 2015.
- 1832 Asset Management opened 84 new positions and closed 129 in Q3 2015.
- 1832 Asset Management's portfolio value fell 19% quarter-over-quarter to $23.9B.
Based on 1832 Asset Management's 13F filing for Q3 2015, filed 12 Nov 2015.